The information provided by GHD in any form is not intended to substitute medical advice but rather serve as a guide and an informational platform for various available treatments and options for such. Reliance on any information provided by GHD Website, its employees, consultants or any other person on its behalf is solely at your own risk and discretion.

© 2020 by Global Healthcare Direct Limited

B Cell Lymphoma


CD19 CAR-T - 90% CR

B-Cell Acute Lymphoblastic Leukemia (B-ALL)

CD19 CAR-T - 90% CR

Multiple Myeloma (MM)



82% Long-Term Survival

Acute Myeloid Leukemia (AML)


Newest Procedure

How to apply for CAR-T therapy?

Global Healthcare Direct works with the top three hospitals that shine in the field of CAR-T treatment.

=> Fill in the below form. Add a short description of your case history and of your current condition. Our case manager will contact you shortly and guide you through. Remember, the earlier you start your treatment, the higher your chances to achieve Complete Remission (CR)

Attach a document
Max File Size 25MB

Our patients story

500+ cases of ALL were treated in our  partner Hospitals, with up to 90% Complete Remission Rates. Contact them with GHD


Chimeric Antigen Receptor T cells therapy (CAR-T) is a cutting-edge treatment, approved by the FDA for a growing number of diseases, primarily hematologic cancers.

In this almost sci-fi treatment, a special medical team engineers the immune system to fight a disease, showing outstanding results.

The introduction of CAR-T treatment to the medical world dramatically changed the course of disease for patients suffering from Acute B Lymphocytic Leukemia (B-ALL), B cell lymphoma, Multiple Myeloma  and Acute Myeloid Leukemia (AML).

Global Health Direct helps you to receive affordable CAR-T treatments from the best medical teams world-wide without compromising on the quality*.

*While the average cost of CAR-T therapy in the US starts at 440,000 USD, our international options will cost only 90,000-110,000 USD.

As part of our CAR-T treatment package, we provide:

  • Online medical consultancies about the efficacy of CAR-T treatment for you

  • CAR-T Cell Treatment in a leading, experienced medical center.

  • Travel and accomodation arrangements (upon request)

  • All airport and hospital transfers

  • Multi-lingual support and local escort teams, also providing translations for your medical documentations

Logo Bilingual.jpeg

Global Healthcare Direct - Your guardian angels abroad

We know that traveling abroad to receive medical treatment can be a stressful and challenging experience.

We promise we can make it much smoother.

Our executive case manager assigned to you will take your case through hospital's bureaucracies, get all your questions answered  and assist you in any way possible to assure that you stay is as comfortable as possible.

Our local team will meet you as you arrive at the local airport, accompany you through your treatment and wave you farewell as you depart back home.

We will bridge all the medical, cultural and lingual gaps for you.

Attach a document
Max File Size 25MB

The Science behind CAR-T Therapy

CAR-T therapy is part of a larger group of next-generation treatments known as ‘Adoptive Cell Transfer’. In these treatments, the patient’s own immune cells are collected and genetically engineered to target and kill cancer cells. The engineered immune

T cells are then proliferated and tested in the laboratory, usually taking days to weeks. The immune cells are then injected back into the patient and the termination

of cancer cells begins.

The outstanding results of CAR-T Cell Treatment
CAR-T first appeared in what is now a well known study focusing on ALL in children resistant to therapy or with recurrent cancer, back in 2015.
It is important to note that ALL is the most common cancer in children and a leading cause of death from childhood cancer.

In this study, 90% of the patients treated with CAR-T stopped showing any signs of ALL (this is called CR or “Complete Remission”). In fact, many of them had no signs of recurrence even long after the treatment, which could be defined as healing. Later studies from several countries showed similar outstanding results.

CAR-T is already approved world-wide
As more results of the impressive effectiveness of CAR-T treatment continued to surface, the American Food and Drug Agency (FDA) approved the treatment for both severe ALL and severe Lymphoma.
It is important to note that CAR-T Therapies are currently also evaluated as first line treatments across the world, including in the hospitals GHD works with.  

What's next?

  1. Contact us: fill this form, send an email or give us a call.

  2. Send us your medical documents. We will translate and forward them to our experts.

  3. We will send you the various possible treatment plans and prices, and help you select the best option for you.

  4. If you’d like, we can help in organizing your flights and accommodation.

  5. Our personal attendant will meet you at the arrivals gate and accompany you throughout the course of your treatment.

  6. We will send the translated release documents and keep in touch with you even after you leave.


Always here for you,

The GHD Team 

Attach a document
Max File Size 25MB